[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

FpML-EQD FpML EQD WG Minutes 1400 LDN Fri 18 July 2008




* Present

Mark Addison, JP Morgan
Jim Brous, Metro Solutions
James Clark, MarkIt
Krishna Devabhaktuni, Citadel Group
Marc Gratacos, ISDA
Rajan Khorana, Citadel Group
Lyteck Lynhiavi, ISDA
Robert Masri, DTCC
Andrew Parry, JP Morgan ( Chair )
Chise Yamamoto, DTCC
Irina Yermakova, ISDA


* Minutes

We do not require any further changes to dividend handling at present. We have previously considered finer distinctions, such as between cash and non cash dividends, and geographic variations, such as special and memorial dividends in the Japanese market. Scheme controlled dividend types would provide the ultimate flexibility, but introduce further complexity, as business rules would have be created and used to control the dividend type

Current ISDA legal drafting is highly compatible with existing FpML structures, and continues to focus on the industry commitments to the Federal Reserve for Derivatives Automation, which firstly requires standardised definition

ISDA Equity Derivatives Operations Working Group have a top 5 list of products for automation, and will next meet on the 30th of July

Another focus of ISDA legal drafting is clarification in the areas of Forwards, Basket Swaps and Options, and Synthetic Futures, where market experience has shown improved documentation is required


* Decisions

1. ISDA EQD Ops WG will guide our product priority order
2. Next meeting 1400 LDN Fri 01 Aug 2008


* Actions

JC communicate ISDA EQD Ops WG top 5 list of products following their 30th July meeting
AP contact Katherine Darras for latest ISDA legal drafting roadmap


Regards

Andrew Parry
+44 20 7325 1486
Exotics and Hybrids Architecture
JP Morgan


This communication is for informational purposes only. It is not intended as an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. All market prices, data and other information are not warranted as to completeness or accuracy and are subject to change without notice. Any comments or statements made herein do not necessarily reflect those of JPMorgan Chase & Co., its subsidiaries and affiliates. This transmission may contain information that is privileged, confidential, legally privileged, and/or exempt from disclosure under applicable law. If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution, or use of the information contained herein (including any reliance thereon) is STRICTLY PROHIBITED. Although this transmission and any attachments are believed to be free of any virus or other defect that might affect any computer system into which it is received and opened, it is the responsibility of the recipient to ensure that it is virus free and no responsibility is accepted by JPMorgan Chase & Co., its subsidiaries and affiliates, as applicable, for any loss or damage arising in any way from its use. If you received this transmission in error, please immediately contact the sender and destroy the material in its entirety, whether in electronic or hard copy format. Thank you. Please refer to http://www.jpmorgan.com/pages/disclosures for disclosures relating to UK legal entities.